VL2397-201

VL2397-201

A Phase 2 Study of VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults With Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, or Allogeneic Hematopoietic Cell Transplant (HCT) Recipients


Treatment


Inclusion criteria


Exclusion criteria


Participating sites

Link